Price movement over the last 24 hours
Agilent Technologies Inc vs Anheuser-Busch Inbev SA — how do they compare? Agilent Technologies Inc trades at $128.5 (market cap $37.04B), while Anheuser-Busch Inbev SA trades at $79.14 (market cap $155.34B). The key difference: Anheuser-Busch Inbev SA is far larger — about 4.2× Agilent Technologies Inc's market cap, and Anheuser-Busch Inbev SA pays the higher dividend (1.69%). Which is the better fit depends on your goals.
| A | BUD | |
|---|---|---|
Market Cap | $37.04B | $155.34B |
Sector | Health | Consumer Staples |
52-Week High | $157.20 | $85.09 |
52-Week Low | $110.24 | $57.10 |
Enterprise Value | $38.59B | $216.53B |
Dividend Yield | 0.78% | 1.69% |
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. After the SABMiller acquisition, the company's portfolio now contains five of the top 10 beer brands by sales and 18 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and U.S.-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev and in 2016 acquired SABMiller.
Read more on BUD →